Aerys Biosciences

Aerys Biosciences is a life sciences company developing a high-throughput platform for functional single-cell analysis. The company's technology leverages droplet microfluidics to screen millions of cells for specific functional properties, enabling the discovery of rare antibodies and cell-based therapies. By integrating functional screening with downstream sequencing, Aerys provides a comprehensive solution for identifying high-value therapeutic leads. The platform is designed to accelerate drug discovery timelines in oncology, immunology, and beyond. Their approach allows researchers to link cellular function directly to genetic information at an unprecedented scale.